person

Esmeralda M.

Country
Portugal
Department
Metabolic Diseases Unit

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
7
Sites with multiple studies

Has run more than one trial at 7 of 11 partner sites.

Specializations

Metabolic and Genetic Disorders

Investigator Martins focuses on rare metabolic conditions and inherited enzyme deficiencies within the Metabolic Diseases Unit.

  • Alpha-1 Antitrypsin Deficiency
  • Phenylketonuria
  • Hereditary Transthyretin Amyloidosis
  • Obesity and Type 2 Diabetes
  • Non‑alcoholic Steatohepatitis (NASH)

Research aims to improve disease-modifying strategies and patient outcomes for these metabolic pathologies.

Autoimmune and Inflammatory Diseases

Work includes clinical evaluation of systemic and organ‑specific autoimmune disorders.

  • Systemic Lupus Erythematosus
  • Atopic Dermatitis
  • Ulcerative Colitis
  • Hidradenitis Suppurativa
  • Rheumatoid Arthritis

Efforts target novel immunomodulatory therapies and biomarker development.

Oncology and Hematologic Malignancies

Investigator engages in trials addressing solid tumours and blood cancers.

  • Non‑Small Cell Lung Cancer
  • Breast Cancer
  • Acute Myeloid Leukemia
  • Diffuse Large B‑Cell Lymphoma
  • Gastric Adenocarcinoma

Focus is on targeted agents, immunotherapies, and combination regimens.

Cardiovascular and Pulmonary Conditions

Research includes heart failure, atherosclerotic disease, and chronic lung disorders.

  • Heart Failure with Preserved Ejection Fraction
  • Atherosclerotic Cardiovascular Disease
  • Pulmonary Arterial Hypertension
  • Chronic Kidney Disease
  • Idiopathic Pulmonary Fibrosis

Goals involve evaluating novel cardiometabolic agents and disease‑modifying inhaled therapies.

Neurological and Neurodegenerative Disorders

Clinical investigations target seizure disorders, movement disorders, and dementias.

  • Epilepsy (Focal and Generalized Seizures)
  • Parkinson’s Disease
  • Frontotemporal Dementia
  • Spinocerebellar Ataxia Type‑3
  • Multiple Sclerosis

Investigations aim to identify disease‑specific therapeutic pathways and improve functional outcomes.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.